1. Home
  2. CORT vs CBT Comparison

CORT vs CBT Comparison

Compare CORT & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • CBT
  • Stock Information
  • Founded
  • CORT 1998
  • CBT 2019
  • Country
  • CORT United States
  • CBT United States
  • Employees
  • CORT N/A
  • CBT N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • CBT Major Chemicals
  • Sector
  • CORT Health Care
  • CBT Industrials
  • Exchange
  • CORT Nasdaq
  • CBT Nasdaq
  • Market Cap
  • CORT 5.9B
  • CBT 4.9B
  • IPO Year
  • CORT N/A
  • CBT N/A
  • Fundamental
  • Price
  • CORT $51.06
  • CBT $89.34
  • Analyst Decision
  • CORT Strong Buy
  • CBT Hold
  • Analyst Count
  • CORT 4
  • CBT 4
  • Target Price
  • CORT $75.25
  • CBT $102.00
  • AVG Volume (30 Days)
  • CORT 798.3K
  • CBT 381.8K
  • Earning Date
  • CORT 02-13-2025
  • CBT 02-03-2025
  • Dividend Yield
  • CORT N/A
  • CBT 1.95%
  • EPS Growth
  • CORT 57.97
  • CBT N/A
  • EPS
  • CORT 1.26
  • CBT 6.72
  • Revenue
  • CORT $628,555,000.00
  • CBT $3,994,000,000.00
  • Revenue This Year
  • CORT $46.29
  • CBT $5.58
  • Revenue Next Year
  • CORT $17.09
  • CBT $3.37
  • P/E Ratio
  • CORT $40.47
  • CBT $13.29
  • Revenue Growth
  • CORT 39.67
  • CBT 1.60
  • 52 Week Low
  • CORT $20.84
  • CBT $70.63
  • 52 Week High
  • CORT $62.22
  • CBT $117.46
  • Technical
  • Relative Strength Index (RSI)
  • CORT 43.80
  • CBT 32.32
  • Support Level
  • CORT $49.42
  • CBT $85.04
  • Resistance Level
  • CORT $52.17
  • CBT $90.32
  • Average True Range (ATR)
  • CORT 1.90
  • CBT 1.92
  • MACD
  • CORT -0.13
  • CBT 0.08
  • Stochastic Oscillator
  • CORT 44.11
  • CBT 48.15

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: